Electrocardiographic Left Atrial Abnormality and B-Type Natriuretic Peptide in a General Japanese Population: NIPPON DATA2010
-
- Shoji Satoshi
- Department of Cardiology, Keio University School of Medicine
-
- Kohsaka Shun
- Department of Cardiology, Keio University School of Medicine
-
- Sawano Mitsuaki
- Department of Cardiology, Keio University School of Medicine
-
- Okamura Tomonori
- Department of Preventive Medicine and Public Health, Keio University School of Medicine
-
- Hirata Aya
- Department of Preventive Medicine and Public Health, Keio University School of Medicine
-
- Sugiyama Daisuke
- Faculty of Nursing and Medical Care, Keio University
-
- Ohkubo Takayoshi
- Department of Hygiene and Public Health, Teikyo University School of Medicine
-
- Nakamura Yasuyuki
- Department of Food Science and Human Nutrition, Ryukoku University
-
- Watanabe Makoto
- Department of Preventive Cardiology, National Cerebral and Cardiovascular Center
-
- Kadota Aya
- Center for Epidemiologic Research in Asia, Shiga University of Medical Science Department of Public Health, Shiga University of Medical Science
-
- Ueshima Hirotsugu
- Center for Epidemiologic Research in Asia, Shiga University of Medical Science Department of Public Health, Shiga University of Medical Science
-
- Okayama Akira
- Research Institute of Strategy for Prevention
-
- Miura Katsuyuki
- Center for Epidemiologic Research in Asia, Shiga University of Medical Science Department of Public Health, Shiga University of Medical Science
この論文をさがす
抄録
<p>Aims: P-wave terminal force in lead V1 (PTFV1) is an electrocardiogram marker of increased left atrial pressure and may be a noninvasive and early detectable marker for future cardiovascular events in the general population compared to serum B-type natriuretic peptide (BNP) concentration. The clinical significance of PTFV1 in the contemporary general population is an area of unmet need. We aimed to demonstrate the correlation between PTFV1 and BNP concentrations in a contemporary representative Japanese population. </p><p>Methods: Among 2,898 adult men and women from 300 randomly selected districts throughout Japan (NIPPON DATA2010), we analyzed 2,556 participants without cardiovascular disease (stroke, myocardial infarction, and atrial fibrillation). Elevated BNP was defined as a value of ≥ 20 pg/mL based on the definition from the Japanese Circulation Society guidelines. </p><p>Results: In total, 125 (4.9%) participants had PTFV1. Participants with PTFV1 were older with a higher prevalence of hypertension, major electrocardiographic findings, and elevated BNP concentrations (13.5 [6.9, 22.8] versus 7.8 [4.4, 14.5] pg/mL; P<0.001). After adjustment for confounders, PTFV1 was correlated with elevated BNP (odds ratio, 1.66; 95% confidence interval, 1.05–2.62; P=0.030). This correlation was consistent among various subgroups and was particularly evident in those aged <65 years or those without a history of hypertension. </p><p>Conclusions: In the contemporary general population cohort, PTFV1 was independently related to high BNP concentration. PTFV1 may be an alternative marker to BNP in identifying individuals at a higher risk of future cardiovascular events in the East Asian population.</p>
収録刊行物
-
- Journal of Atherosclerosis and Thrombosis
-
Journal of Atherosclerosis and Thrombosis 28 (1), 34-43, 2021-01-01
一般社団法人 日本動脈硬化学会
- Tweet
キーワード
詳細情報
-
- CRID
- 1391694356248563328
-
- NII論文ID
- 130007965091
-
- ISSN
- 18803873
- 13403478
-
- PubMed
- 32188793
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- PubMed
- CiNii Articles
- KAKEN
-
- 抄録ライセンスフラグ
- 使用不可